| Product NDC: | 60505-2596 | 
| Proprietary Name: | Alendronate Sodium | 
| Non Proprietary Name: | Alendronate Sodium | 
| Active Ingredient(s): | 70 mg/1 & nbsp; Alendronate Sodium | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 60505-2596 | 
| Labeler Name: | Apotex Corp. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA077982 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20080804 | 
| Package NDC: | 60505-2596-4 | 
| Package Description: | 1 BLISTER PACK in 1 CARTON (60505-2596-4) > 4 TABLET in 1 BLISTER PACK | 
| NDC Code | 60505-2596-4 | 
| Proprietary Name | Alendronate Sodium | 
| Package Description | 1 BLISTER PACK in 1 CARTON (60505-2596-4) > 4 TABLET in 1 BLISTER PACK | 
| Product NDC | 60505-2596 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Alendronate Sodium | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20080804 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Apotex Corp. | 
| Substance Name | ALENDRONATE SODIUM | 
| Strength Number | 70 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |